$8.50 -0.70 (-7.61%)
2/10/2012 3:52 PM

Gentium S.p.A. (ADR) (NASDAQ:GENT)

CAPS Rating: 2 out of 5

A biopharmaceutical company engaged in the research, development and manufacture of drugs to treat and prevent a variety of vascular diseases and conditions related to cancer and cancer treatments.

Featured Broker Partners


Advertisement